Callan Family Office’s AB InBev BUD Stock Holding History

Callan Family Office’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.38M	Sell	101,755 -3,412	-3%	-$268K	0.16%	120
2026 Q1	$7.3M	Sell	105,167 -2,170	-2%	-$157K	0.17%	125
2025 Q4	$6.87M	Buy	107,337 +20,549	+24%	+$1.28M	0.15%	138
2025 Q3	$5.17M	Sell	86,788 -6,738	-7%	-$424K	0.16%	142
2025 Q2	$6.43M	Buy	93,526 +66,413	+245%	+$4.46M	0.2%	121
2025 Q1	$1.67M	Sell	27,113 -788	-3%	-$43.1K	0.13%	147
2024 Q4	$1.4M	Buy	+27,901	New	+$1.61M	0.09%	191
2023 Q2	–	Sell	-10,200	Closed	-$681K	–	116
2023 Q1	$681K	Buy	+10,200	New	+$616K	0.17%	77

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Callan Family Office's BUD Position: Q2 2026 in Review

Callan Family Office reduced its AB InBev (BUD) stake by 3.2% in Q2 2026, selling an estimated $268K and leaving 101,755 shares worth $8.38M. The position accounts for 0.16% of the portfolio, ranked #120.

Callan Family Office first reported a position in BUD in Q1 2023 and has held it in 8 quarters since. 616 funds tracked by Wall St. Rank hold BUD as of Q2 2026.

Callan Family Office held 101,755 shares of AB InBev worth $8.38M as of Q2 2026.
Callan Family Office sold 3,412 AB InBev shares in Q2 2026, an estimated $268K.
AB InBev made up 0.16% of Callan Family Office's portfolio in Q2 2026, its #120 holding.
Callan Family Office first reported a position in AB InBev in Q1 2023 and has held it in 8 quarters since.
616 funds tracked by Wall St. Rank held AB InBev as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.